Clik here to view.
H3 Biomedicine to Present New Data on H3B-6527, an FGFR4 Inhibitor, at the...
CAMBRIDGE, Mass. H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisai’s global...
View ArticleClik here to view.
SanBio Names Mohammad El-Kalay New Technical Operations SVP
MOUNTAIN VIEW, Calif. SanBio, Inc., a leader in regenerative cell therapies, today announced the appointment of Mohammad El-Kalay, PhD, as Senior Vice President of Technical Operations. In this...
View ArticleClik here to view.
Takeda to Feature ALUNBRIG™ (brigatinib) Data from Pivotal Phase 2 ALTA Trial...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will present four company-sponsored abstracts, including one oral presentation,...
View ArticleClik here to view.
旅への渇望はDNAに刻み込まれているのか？キュリオ・コレクションbyヒルトンが「好奇心遺伝子プログラム」を立ち上げ
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米バージニア州マクリーン （ビジネスワイヤ） — あなたは生まれながらに好奇心が旺盛ですか？...
View ArticleClik here to view.
武田在第18届世界肺癌大会上呈报通过枢纽性2期ALTA 临床试验获得的ALUNBRIG™ (brigatinib)数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，该公司将在国际肺癌研究协会(IASLC)的第18届世界肺癌大会(WCLC)上呈报4篇由公司资助的研究摘要，其中包括一场口头报告，本届大会将于10月15-18日在日本横滨召开。本届会议上的报告将突出强调武田在开发ALUNBRIGTM...
View ArticleClik here to view.
武田薬品、第18回世界肺がん学会議でピボタル第2相ALTA試験から得たALUNBRIG™（ブリガチニブ）のデータを発表へ
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Foundation Medicine to Present Validation for FoundationOne CDx™, a...
CAMBRIDGE, Mass. Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company will present validation data for FoundationOne CDx, its comprehensive genomic profiling assay, at the...
View ArticleClik here to view.
旅行癖是根植于我们基因的吗？Curio Collection by Hilton推出“好奇基因”项目
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 弗吉尼亚州麦克莱恩 (美国商业资讯)–您天生好奇吗？这个秋季，希尔顿(NYSE: HLT)的14家市场领先品牌之一Curio Collection by...
View ArticleClik here to view.
GenePeeks Expands Distribution to India with Exclusive Agreement with CORE...
CAMBRIDGE, Mass. GenePeeks, Inc., a computational genomics company focused on transforming disease risk analysis, today announced an exclusive distribution agreement with CORE Diagnostics, a...
View ArticleClik here to view.
Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class...
SAN DIEGO Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, today announced updated results from its clinical trials, including the STARTRK-2 trial, of...
View ArticleClik here to view.
Konica Minolta and Innovation Network Corporation of Japan Close Acquisition...
TOKYO Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902) (ISIN: JP3300600008) and Innovation Network Corporation of Japan (“INCJ”) today announced the close of their joint acquisition of Ambry...
View ArticleClik here to view.
アーサー・D・リトル、遺伝子検査の急成長および 業界全体への影響に関するレポートを発表
マサチューセッツ州ボストン 戦略的思考、革新的知見、そして技術集約型の新産業に関する専門知識で知られるコンサルタント会社、アーサー・D・リトルは本日、診断法の未来、個人向け遺伝子サービスの成長ポテンシャルについて論じたレポートを発表しました。...
View ArticleClik here to view.
Arthur D. Little Issues Insights on Genetic Testing’s Rapid Growth and...
BOSTON Arthur D. Little, a consultancy known for strategic thinking, innovative insight and expertise in technology-intensive and emerging industries, today issued a report covering the future of...
View ArticleClik here to view.
Altemia™治疗镰状细胞病(SCD)患儿获得临床成功
佛罗里达州里维埃拉海滩 — (美国商业资讯) — Sancilio Pharmaceuticals Company, Inc. (SPCI)今天宣布，一项评估Altemia™口服软明胶胶囊治疗5-17岁镰状细胞病患儿有效性和安全性的临床研究获得阳性先期结果 (https://clinicaltrials.gov/ct2/show/NCT02973360)。...
View ArticleClik here to view.
Co-Diagnostics, Inc. Manufacturing Joint Venture Breaks Ground in India
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, and Synbiotics...
View ArticleClik here to view.
Chugai’s ALK Inhibitor “Alecensa®” Approved for the Treatment of First Line...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Genentech Inc., a member of the Roche Group, obtained approval from the U.S. Food and Drug Administration (FDA), for...
View ArticleClik here to view.
FDNA Expands into Asia-Pacific Markets
BANGKOK (APSHG Conference) – FDNA, developer of Face2Gene, today announces expansion of its growing presence in the Asia-Pacific region with the launch of its new Center of Research Excellence at...
View ArticleClik here to view.
Progenity宣布完成1.25亿美元融资，用于产前-女性健康遗传学和胃肠病/炎性肠病精准医学
圣迭戈 (美国商业资讯) — 私营生物技术公司Progenity Inc.今天宣布完成一笔包含资产和债务的价值1.25亿美元的私募B轮融资。该融资由其现有的投资者之一Athyrium Capital Management掌管的一家基金领投。 Progenity Inc.执行董事长、创始人Harry...
View ArticleClik here to view.
プロジェニティ、妊婦医療の遺伝および消化管/炎症性腸疾患精密医学に向けた1億2500万ドルの資金調達の完了を発表
サンディエゴ （ビジネスワイヤ） — 非公開のバイオ技術企業のプロジェニティは本日、株式と負債で構成される私募による1億2500万ドルのシリーズB資金調達を完了したと発表しました。この資金調達は、既存の投資家のアシリアム・キャピタル・マネジメントが管理するファンドが主幹事を務めました。...
View ArticleClik here to view.
SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre...
SINGAPORE SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences at the National University of...
View Article